From: Is amyotrophic lateral sclerosis/frontotemporal dementia an autophagy disease?
Gene symbol | Protein | Cellular functions | The effect of the genetic variants | Autophagy involvement |
---|---|---|---|---|
C9ORF72 | C9orf72 | Proteostasis and vesicle dynamics | Loss/gain of function | |
TBK1 | TBK1 (TANK-binding kinase 1) | Proteostasis and immunity | Loss of function | Phosphorylates autophagy receptors (p62 and OPTN); regulates selective autophagy. [48,49,50,51] |
OPTN | Optineurin | Proteostasis, vesicle trafficking and axon homeostasis | Loss of function | A substrate of TBK1 and autophagy receptor protein; selective autophagy. [25, 48, 49] |
SQSTM1 | p62 | Pproteostasis, amino acid sensing, DNA damage response, and oxidative stress | Loss of function | A substrate of TBK1 and ULK1; autophagy receptor; selective autophagy.[25, 50, 68] |
UBQLN2 | Ubiquilin-2 (UBQLN2) | Proteasome, proteostasis, and vesicle trafficking | Gain/loss of function | |
TARDBP | TDP-43 | RNA regulation | Loss/gain of function | Regulates autophagy initiation and autophagosome-lysosome fusion. [103] |
FUS | FUS (fused in sarcoma) | RNA regulation, and DNA damage repair | Loss of function | ALS-linked mutations, P525L and R522G, impair autophagy. [165] |
VCP | Valosin-containing protein | ER-associated degradation, DNA damage, and membrane dynamics | Loss of function | Regulates the clearance of lysosomes. [128] |
SOD1 | Superoxide dismutase 1 | Dismutation reaction | Gain of function | |
ALS2 | Alsin | Proteostasis and endosome biogenesis | Loss of function | Pathogenic mutations in ALS2 disrupt the formation of amphisomes. [150] |
VAPB | Vesicle-associated membrane protein-associated protein B/C | Proteostasis, calcium homeostasis, and proteins trafficking | Loss of function | Regulates ER-mitochondrial contact. [155] |
SigR1 | Sigma receptor-1 | Proteostasis, Ca2+ signaling, ion channel activity, synaptic plasticity. | Loss of function |